Kimberly-Clark buys Tylenol-maker Kenvue in more than $40bn deal
Source: BBC
Natalie ShermanBusiness reporterAFP via Getty ImagesThe Trump administration linked use of Tylenol during pregnancy to autism, despite what scientists say is inconclusive evidenceKimberly-Clark is set to buy Kenvue, the maker of Tylenol, which has faced attacks from the White House and flagging demand for its products. The more-than $40bn (£30.5bn) cash-and-stock deal would create a consumer giant, with a…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at BBC